4/8
07:00 am
gkos
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
Low
Report
Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
4/6
11:27 pm
gkos
Does Glaukos (GKOS) Using Epioxa at ASCRS Hint at a Broader Corneal-Health Strategy Shift? [Yahoo! Finance]
Low
Report
Does Glaukos (GKOS) Using Epioxa at ASCRS Hint at a Broader Corneal-Health Strategy Shift? [Yahoo! Finance]
4/6
07:22 am
gkos
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting [Yahoo! Finance]
Medium
Report
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting [Yahoo! Finance]
4/6
07:00 am
gkos
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Low
Report
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
3/19
07:00 am
gkos
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
Low
Report
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
2/26
03:27 am
gkos
Should Glaukos' (GKOS) Big 2026 Sales Target and ESOP Shelf Filing Require Action From Investors? [Yahoo! Finance]
Low
Report
Should Glaukos' (GKOS) Big 2026 Sales Target and ESOP Shelf Filing Require Action From Investors? [Yahoo! Finance]
2/21
02:08 am
gkos
Glaukos Corporation Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Glaukos Corporation Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/18
08:13 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $131.00 price target on the stock.
High
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $131.00 price target on the stock.
2/18
08:06 am
gkos
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
High
Report
Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
2/18
07:01 am
gkos
Glaukos (NYSE:GKOS) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
High
Report
Glaukos (NYSE:GKOS) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
2/18
12:19 am
gkos
Glaukos Corp (GKOS) Q4 2025 Earnings Call Highlights: Record Sales and Strong Growth Outlook [Yahoo! Finance]
High
Report
Glaukos Corp (GKOS) Q4 2025 Earnings Call Highlights: Record Sales and Strong Growth Outlook [Yahoo! Finance]
2/17
11:18 pm
gkos
Glaukos outlines 2026 sales target of $600M–$620M as iDose TR and Epioxa drive growth momentum [Seeking Alpha]
High
Report
Glaukos outlines 2026 sales target of $600M–$620M as iDose TR and Epioxa drive growth momentum [Seeking Alpha]
2/17
11:18 pm
gkos
Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/17
10:47 pm
gkos
Glaukos Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Glaukos Q4 Earnings Call Highlights [Yahoo! Finance]
2/17
07:10 pm
gkos
Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]
High
Report
Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]
2/17
06:40 pm
gkos
Glaukos (GKOS) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
High
Report
Glaukos (GKOS) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/17
04:45 pm
gkos
Glaukos: Q4 Earnings Snapshot [Yahoo! Finance]
High
Report
Glaukos: Q4 Earnings Snapshot [Yahoo! Finance]
2/17
04:05 pm
gkos
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
High
Report
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
2/4
04:27 pm
gkos
iVeena Delivery Systems Announces Strategic Leadership Promotions to Accelerate Growth and Scientific Innovation [Yahoo! Finance]
Low
Report
iVeena Delivery Systems Announces Strategic Leadership Promotions to Accelerate Growth and Scientific Innovation [Yahoo! Finance]
2/3
07:12 am
gkos
Glaukos (NYSE:GKOS) was upgraded by analysts at William Blair to a "strong-buy" rating.
Low
Report
Glaukos (NYSE:GKOS) was upgraded by analysts at William Blair to a "strong-buy" rating.
2/2
12:20 am
gkos
A Look At Glaukos (GKOS) Valuation After FDA Label Expansion For iDose TR [Yahoo! Finance]
Low
Report
A Look At Glaukos (GKOS) Valuation After FDA Label Expansion For iDose TR [Yahoo! Finance]
2/1
10:36 pm
gkos
Assessing Glaukos (GKOS) After Recent Share Price Rebound And DCF Upside Potential [Yahoo! Finance]
Low
Report
Assessing Glaukos (GKOS) After Recent Share Price Rebound And DCF Upside Potential [Yahoo! Finance]
2/1
07:51 pm
gkos
How Investors May Respond To Glaukos (GKOS) FDA-Backed Repeat Protocol For iDose TR Implant [Yahoo! Finance]
Low
Report
How Investors May Respond To Glaukos (GKOS) FDA-Backed Repeat Protocol For iDose TR Implant [Yahoo! Finance]
1/31
07:03 pm
gkos
Director Sells GKOS 15,000 Shares for $1.9 Million [Yahoo! Finance]
Low
Report
Director Sells GKOS 15,000 Shares for $1.9 Million [Yahoo! Finance]
1/29
10:32 am
gkos
Wells sees potential upside after Glaukos' iDose repeat dosing label approved [Yahoo! Finance]
Low
Report
Wells sees potential upside after Glaukos' iDose repeat dosing label approved [Yahoo! Finance]